Novel Clinical Trials

Driving innovative research to transform novel ideas to better human life

The research community across CU Anschutz Medical Campus performs hundreds of clinical trials in a broad range of research fields – all crucial to answering difficult scientific and health questions, which can lead to the development of new and enhanced drugs and treatments. 

The Novel Clinical Trials Program strives to provide the necessary expertise and resources to expand the research infrastructure to support new and innovative study designs. The program will primarily focus on Decentralized Clinical Trials (DCT).

What are DCTs?

A clinical trial where some or all of the trial activities occur at locations other than the traditional clinical trial sites.


  1. Connect investigators to existing resources
  2. Collaborate with internal and external stakeholders
  3. Identify resource, personnel, and infrastructure needs
  4. Serve as a central resource to help operationalize novel clinical trials

DCT Working Group

A leadership advisory group that helps the CU Anschutz Research Community that assesses resource, infrastructure, and personnel needs and assists with operationalizing decentralized study designs and approaches.

DCT Community of Practice

A platform for all members of the CU Anschutz Research Community to come together to share ideas, discuss challenges, and troubleshoot solutions for novel ideas and decentralized clinical trials.

More to come in 2024…

Contact Us

Jama Bettis, MSW and Kiley B. Vander Wyst, PhD, MPH

Visualize the Spectrum of Novel Clinical Trials

Our expertise is the development, implementation, and oversight of decentralized, virtual, hybrid, and pragmatic clinical trials; here's how it works:


Campus Resources

Note: This list of campus resources is in development, and therefore, not exhaustive. If you are aware of another campus resource that is not on this list, please email us.

External Resources

Wearable Devices

Universities and Academic Medical Centers

CMS Login